Chlamydia pneumoniae Induces Tissue Factor Expression in Mouse Macrophages via Activation of Egr-1 and the MEK-ERK1/2 Pathway
- 7 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 92 (4) , 394-401
- https://doi.org/10.1161/01.res.0000059982.43865.75
Abstract
Recent studies have suggested that infection with Chlamydia pneumoniae (C pneumoniae) may contribute to the instability of atherosclerotic plaques and thrombosis and is associated with acute coronary events. Tissue factor (TF), a potent prothrombotic molecule, is expressed by macrophages and other cell types within atherosclerotic lesions and plays an essential role in thrombus formation after plaque rupture. Therefore the effects of C pneumoniae on induction of TF expression in macrophages were investigated. Infection of RAW mouse macrophages with C pneumoniae induced a time-dependent increase in procoagulant activity, expression of TF protein, and TF mRNA. C pneumoniae infection stimulated increased binding of nuclear proteins to the consensus DNA sequence for Egr-1, a key response element within the TF promoter, and increased the expression of Egr-1 protein. Transient transfections of RAW cells with mutated TF promoter constructs showed that the Egr-1 binding region is an important transcriptional regulator of C pneumoniae–induced TF expression. Furthermore, C pneumoniae–stimulated phosphorylation of ERK1/2 and Elk-1 and pharmacological inhibition of mitogen-activated protein kinase activity reduced the expression of TF and Egr-1. Antibody and polymyxin B blocking of the Toll-like receptor 4 (TLR4) partially reduced the C pneumoniae–induced expression of TF and Egr-1. In conclusion, the C pneumoniae–induced increase in TF expression in macrophages is mediated in part by Egr-1, signaling through TLR4, and activation of the MEK-ERK1/2 pathway.Keywords
This publication has 32 references indexed in Scilit:
- Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor κB, and Egr-1Journal of Biological Chemistry, 2002
- Elevated Egr-1 in Human Atherosclerotic Cells Transcriptionally Represses the Transforming Growth Factor-β Type II ReceptorPublished by Elsevier ,2000
- Chlamydial Virulence Determinants in Atherogenesis: The Role of Chlamydial Lipopolysaccharide and Heat Shock Protein 60 in Macrophage‐Lipoprotein InteractionsThe Journal of Infectious Diseases, 2000
- High-level expression of Egr-1 and Egr-1–inducible genes in mouse and human atherosclerosisJournal of Clinical Investigation, 2000
- Cellular Oxidation of Low‐Density Lipoprotein byChlamydia pneumoniaeThe Journal of Infectious Diseases, 1999
- Chlamydia pneumoniaeInfection Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient MiceThe Journal of Infectious Diseases, 1999
- The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniaeJournal of Clinical Investigation, 1999
- Chlamydia Linked to AtherosclerosisPublished by American Association for the Advancement of Science (AAAS) ,1996
- Transcriptional Regulation of the Tissue Factor Gene in Human Epithelial Cells Is Mediated by Sp1 and EGR-1Published by Elsevier ,1996
- Regulation of the Tissue Factor Promoter in Endothelial CellsJournal of Biological Chemistry, 1995